Scientists design therapeutic approaches for cancer around mutations and variations that affect disease onset and progression. However, these determinants can differ across populations, and what ...
Scientists have developed ThermoCas9, a CRISPR enzyme that can distinguish cancer DNA from healthy DNA by reading methylation patterns, potentially reducing off-target edits. In lab tests, it ...
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
Researchers have developed ThermoCas9, a CRISPR enzyme that can distinguish cancer cells from healthy ones by reading DNA methylation patterns. In lab tests, it selectively edited breast cancer cell ...
What is the application of CRISPR for cancer treatment that Caribou is trying to pursue? Caribou is advancing the development of allogeneic CAR-T cell therapies for hematologic malignancies and ...
“While recent single-cell multiomics studies and CRISPR screens in murine NK cells have expanded our understanding, actionable genomic targets in primary human NK cells have remained largely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results